Cite
HARVARD Citation
Nirogi, R. et al. (2022). Effect of masupirdine (SUVN‐502) on cognition in patients with moderate Alzheimer's disease: A randomized, double‐blind, phase 2, proof‐of‐concept study. Alzheimer's & dementia. 8 (1), p. n/a. [Online].